Genetic determinants of cerebrospinal fluid metabolites and risk of Guillain-Barré syndrome: A bidirectional two-sample Mendelian randomization study

Xiangjia Qi,Liqian Gao,Lifeng Qi
DOI: https://doi.org/10.1097/md.0000000000040352
IF: 1.6
2024-11-13
Medicine
Abstract:Guillain-Barré syndrome (GBS), an immune-mediated polyradiculoneuropathy, is the leading cause of acute flaccid paralysis worldwide, with approximately 100,000 new cases occurring each year. [ 1 ] Most patients experience a sudden onset of neurological symptoms following an infectious illness, which leads to progressive limb weakness lasting up to 4 weeks before reaching a plateau. [ 2 ] GBS remains a serious condition, with a mortality rate of approximately 5% and up to 20% of patients unable to walk independently after 1 year. [ 3 ]
medicine, general & internal
What problem does this paper attempt to address?